{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:14:21Z","timestamp":1783977261931,"version":"3.55.0"},"reference-count":30,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objectives: Carbon-ion radiotherapy (CIRT) is now covered by Japan\u2019s health insurance for patients with hepatocellular carcinoma (HCC) tumors measuring \u22654 cm. However, no studies have compared intrahepatic control between CIRT and hepatectomy in these patients. Methods: We retrospectively analyzed intrahepatic control in 51 patients with HCC tumors \u22654 cm. Among them, 38 underwent CIRT (60 Gy in four fractions), while 13 underwent systematic hepatectomy. Intrahepatic recurrence was classified as local or intrahepatic distant. We evaluated local, distant, and total intrahepatic control rates at 1 and 2 years. Results: In the CIRT group, the local control rates at 1 and 2 years were 81.5% and 76.3%, whereas the intrahepatic distant control rates were 68.5% and 63.2% (p = 0.0495), respectively. Among patients aged &lt;80 years, the 2-year intrahepatic control rate did not significantly differ between CIRT and hepatectomy. However, it was significantly lower in patients aged \u226580 years treated with CIRT than in those aged &lt;80 years (73.7% vs. 42.1%, p = 0.0100), with similar trends in local (92.3% vs. 63.2%, p = 0.0381) and distant control (78.9% vs. 47.3%, p = 0.0259). Conclusions: CIRT may be as effective as hepatectomy for HCC tumors \u22654 cm in patients aged &lt;80 years, but its efficacy declines in older patients, warranting age-tailored strategies.<\/jats:p>","DOI":"10.3390\/jcm14165678","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T14:32:36Z","timestamp":1754922756000},"page":"5678","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment Outcomes in Patients Receiving Carbon-Ion Radiotherapy Versus Hepatectomy for Hepatocellular Carcinoma (\u22654 cm): A Retrospective Study in Japan"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2035-1940","authenticated-orcid":false,"given":"Keita","family":"Maki","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9355-1837","authenticated-orcid":false,"given":"Hiroaki","family":"Haga","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5670-7505","authenticated-orcid":false,"given":"Tomohiro","family":"Katsumi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Hoshikawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Radiology, Division of Radiation Oncology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Surgery I, Yamagata University Graduate School of Medical Science, Yamagata 990-9585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichiro","family":"Sugawara","sequence":"additional","affiliation":[{"name":"Department of Surgery I, Yamagata University Graduate School of Medical Science, Yamagata 990-9585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Koto","sequence":"additional","affiliation":[{"name":"Department of Radiology, Division of Radiation Oncology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuyuhiko","family":"Motoi","sequence":"additional","affiliation":[{"name":"Department of Surgery I, Yamagata University Graduate School of Medical Science, Yamagata 990-9585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5623-4250","authenticated-orcid":false,"given":"Yoshiyuki","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Yamagata University Faculty of Medicine, Yamagata 990-9585, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/XCS.0000000000000532","article-title":"Hepatic resection vs particle therapy as an initial treatment for single hepatocellular carcinoma: Bi-institutional propensity score-matched analysis","volume":"236","author":"Omiya","year":"2023","journal-title":"J. Am. Coll. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1269\/jrr.48.A1","article-title":"Clinical results of carbon ion radiotherapy at NIRS","volume":"48","author":"Tsujii","year":"2007","journal-title":"J. Radiat. Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3350\/cmh.2023.0217","article-title":"Carbon ion radiotherapy in the treatment of hepatocellular carcinoma","volume":"29","author":"Byun","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1002\/cncr.30816","article-title":"Progressive hypofractionated carbon-ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials","volume":"123","author":"Kasuya","year":"2017","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Shiba, S., Abe, T., Shibuya, K., Katoh, H., Koyama, Y., Shimada, H., Kakizaki, S., Shirabe, K., Kuwano, H., and Ohno, T. (2017). Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma. BMC Cancer, 17.","DOI":"10.1186\/s12885-017-3724-4"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1111\/liv.13969","article-title":"Short-course carbon-ion radiotherapy for hepatocellular carcinoma: A multi-institutional retrospective study","volume":"38","author":"Shibuya","year":"2018","journal-title":"Liver Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.21873\/anticanres.12631","article-title":"No deterioration in the clinical outcomes of carbon ion radiotherapy for sarcopenia patients with hepatocellular carcinoma","volume":"38","author":"Shiba","year":"2018","journal-title":"Anticancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13014-019-1347-4","article-title":"A comparison of carbon ion radiotherapy and transarterial chemoembolization treatment outcomes for single hepatocellular carcinoma: A propensity score matching study","volume":"14","author":"Shiba","year":"2019","journal-title":"Radiat. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.adro.2019.09.007","article-title":"Long-term results of high-dose 2-fraction carbon ion radiation therapy for hepatocellular carcinoma","volume":"5","author":"Yasuda","year":"2020","journal-title":"Adv. Radiat. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.radonc.2018.10.009","article-title":"A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger","volume":"132","author":"Shibuya","year":"2019","journal-title":"Radiother. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13014-020-01634-z","article-title":"Clinical impact of hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma","volume":"15","author":"Shiba","year":"2020","journal-title":"Radiat. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000520277","article-title":"Efficacy and safety of 4 fractions of carbon-ion radiation therapy for hepatocellular carcinoma: A prospective study","volume":"11","author":"Shibuya","year":"2021","journal-title":"Liver Cancer"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/hepr.13827","article-title":"Carbon-ion radiotherapy versus radiofrequency ablation as initial treatment for early-stage hepatocellular carcinoma","volume":"52","author":"Fujita","year":"2022","journal-title":"Hepatol. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"14004","DOI":"10.1002\/cam4.6046","article-title":"Clinical impact of carbon-ion radiotherapy on hepatocellular carcinoma with child-Pugh B cirrhosis","volume":"12","author":"Hiroshima","year":"2023","journal-title":"Cancer Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ijrobp.2023.02.036","article-title":"Repeated carbon-ion radiation therapy for intrahepatic recurrent hepatocellular carcinoma","volume":"116","author":"Tomizawa","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/cas.15633","article-title":"Carbon ion radiotherapy with pencil beam scanning for hepatocellular carcinoma: Long-term outcomes from a phase I trial","volume":"114","author":"Hong","year":"2023","journal-title":"Cancer Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.2147\/JHC.S429186","article-title":"pencil beam scanning carbon ion radiotherapy for hepatocellular carcinoma","volume":"10","author":"Zhang","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/hepr.13844","article-title":"Reevaluation of Makuuchi\u2019s criteria for resecting hepatocellular carcinoma: A Japanese nationwide survey","volume":"53","author":"Aramaki","year":"2023","journal-title":"Hepatol. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/hepr.13892","article-title":"Clinical practice guidelines for hepatocellular carcinoma: The japan society of hepatology 2021 version (5th JSH-HCC guidelines)","volume":"53","author":"Hasegawa","year":"2023","journal-title":"Hepatol. Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00270-012-0394-0","article-title":"Chemoembolization with doxorubicin-eluting beads for unresectable hepatocellular carcinoma: Five-year survival analysis","volume":"35","author":"Malagari","year":"2012","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.3748\/wjg.v25.i32.4614","article-title":"Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions","volume":"25","author":"Inchingolo","year":"2019","journal-title":"World. J. Gastroenterol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Tanaka, T., Takata, K., Miyayama, T., Shibata, K., Fukuda, H., Yamauchi, R., Fukunaga, A., Yokoyama, K., Shakado, S., and Sakisaka, S. (2023). Long-term outcome and eligibility of radiofrequency ablation for hepatocellular carcinoma over 3.0 cm in diameter. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-43516-w"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.21037\/tcr.2018.12.10","article-title":"The albumin-bilirubin score stratifies the outcomes of Child-Pugh class A patients after resection of hepatocellular carcinoma","volume":"8","author":"Ruzzenente","year":"2019","journal-title":"Transl. Cancer Res"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.21873\/anticanres.16007","article-title":"Long-term outcomes and prognostic factors of stereotactic body radiotherapy for hepatocellular carcinoma","volume":"42","author":"Nagata","year":"2022","journal-title":"Anticancer Res."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Shehta, A., Elsabbagh, A.M., Medhat, M., Farouk, A., Monier, A., Said, R., Salah, T., Elshobari, M., Fouad, A., and Elghawalby, A.N. (2024). Impact of tumor size on the outcomes of hepatic resection for hepatocellular carcinoma: A retrospective study. BMC Surg., 24.","DOI":"10.1186\/s12893-023-02296-w"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"23416","DOI":"10.18632\/aging.203620","article-title":"Impact of aging on primary liver cancer: Epidemiology, pathogenesis and therapeutics","volume":"13","author":"Macias","year":"2021","journal-title":"Aging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Blasco","year":"2013","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s13045-020-00986-z","article-title":"Immunosenescence: A key player in cancer development","volume":"13","author":"Lian","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/hepr.12916","article-title":"Clinical outcomes of stereotactic body radiotherapy for elderly patients with hepatocellular carcinoma","volume":"48","author":"Teraoka","year":"2018","journal-title":"Hepatol. Res."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5678\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:24:57Z","timestamp":1760034297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/16\/5678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":30,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["jcm14165678"],"URL":"https:\/\/doi.org\/10.3390\/jcm14165678","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]}}}